Skip to search formSkip to main contentSkip to account menu

vibegron

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
MP54-08 EFFECTS OF VIBEGRON, A NEW β3-ADRENOCEPTOR AGONIST, ON DETRUSOR OVERACTIVITY AND REMODELING IN A MOUSE MODEL OF SPINAL CORD INJURY (SCI)
INTRODUCTION AND OBJECTIVE:Vibegron is a new β3-adrenoceptor agonist that was approved for the treatment of overreactive bladder… 
2019
2019
Once-Daily Vibegron 75 mg Demonstrates Statistically Significant Benefits on Key Secondary Endpoints Including Quality of Life in Patients With OAB: Data From an International Phase 3 Trial (EMPOWUR)
2019
2019
Efficacy of vibegron, a novel selective β3-adrenoreceptor agonist, on urgency urinary incontinence with overactive bladder: Post-hoc analysis of phase III study